Advertisement

Comparison of Complications and Outcomes to One Year of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis

Published:February 23, 2012DOI:https://doi.org/10.1016/j.amjcard.2012.01.364
      Comparisons of transcatheter aortic valve implantation (TAVI) to surgical aortic valve replacement (SAVR) in patients with severe aortic stenosis remain sparse or limited by a short follow-up. We sought to evaluate early and midterm outcomes of consecutive patients (n = 618) undergoing successful TAVI (n = 218) or isolated SAVR (n = 400) at 2 centers. The primary end point was incidence of Valvular Academic Research Consortium–defined major adverse cerebrovascular and cardiac events (MACCEs) up to 1 year. Control of potential confounders was attempted with extensive statistical adjustment by covariates and/or propensity score. In-hospital MACCEs occurred in 73 patients (11.8%) and was more frequent in patients treated with SAVR compared to those treated with TAVI (7.8% vs 14.0%, p = 0.022). After addressing potential confounders using 3 methods of statistical adjustment, SAVR was consistently associated with a higher risk of MACCEs than TAVI, with estimates of relative risk ranging from 2.2 to 2.6 at 30 days, 2.3 to 2.5 at 6 months, and 2.0 to 2.2 at 12 months. This difference was driven by an adjusted increased risk of life-threatening bleeding at 6 and 12 months and stroke at 12 months with SAVR. Conversely, no differences in adjusted risk of death, stroke and myocardial infarction were noted between TAVI and SAVR at each time point. In conclusion, in a large observational registry with admitted potential for selection bias and residual confounding, TAVI was not associated with a higher risk of 1-year MACCEs compared to SAVR.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rodés-Cabau J.
        • Webb J.G.
        • Cheung A.
        • Ye J.
        • Dumont E.
        • Feindel C.M.
        • Osten M.
        • Natarajan M.K.
        • Velianou J.L.
        • Martucci G.
        • DeVarennes B.
        • Chisholm R.
        • Peterson M.D.
        • Lichtenstein S.V.
        • Nietlispach F.
        • Doyle D.
        • DeLarochellière R.
        • Teoh K.
        • Chu V.
        • Dancea A.
        • Lachapelle K.
        • Cheema A.
        • Latter D.
        • Horlick E.
        Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience.
        J Am Coll Cardiol. 2010; 55: 1080-1090
        • Eltchaninoff H.
        • Prat A.
        • Gilard M.
        • Leguerrier A.
        • Blanchard D.
        • Fournial G.
        • Iung B.
        • Donzeau-Gouge P.
        • Tribouilloy C.
        • Debrux J.L.
        • Pavie A.
        • Gueret P.
        • FRANCE Registry Investigators
        Transcatheter aortic valve implantation: early results of the France (French Aortic National CoreValve and Edwards) registry.
        Eur Heart J. 2011; 32: 191-197
        • Zahn R.
        • Gerckens U.
        • Grube E.
        • Linke A.
        • Sievert H.
        • Eggebrecht H.
        • Hambrecht R.
        • Sack S.
        • Hauptmann K.E.
        • Richardt G.
        • Figulla H.R.
        • Senges J.
        • German Transcatheter Aortic Valve Interventions–Registry Investigators
        Transcatheter aortic valve implantation: first results from a multi-centre real-world registry.
        Eur Heart J. 2011; 32: 198-204
        • Tamburino C.
        • Capodanno D.
        • Ramondo A.
        • Petronio A.S.
        • Ettori F.
        • Santoro G.
        • Klugmann S.
        • Bedogni F.
        • Maisano F.
        • Marzocchi A.
        • Poli A.
        • Antoniucci D.
        • Napodano M.
        • De Carlo M.
        • Fiorina C.
        • Ussia G.P.
        Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis.
        Circulation. 2011; 123: 299-308
        • Kodali S.K.
        • O'Neill W.W.
        • Moses J.W.
        • Williams M.
        • Smith C.R.
        • Tuzcu M.
        • Svensson L.G.
        • Kapadia S.
        • Hanzel G.
        • Kirtane A.J.
        • Leon M.B.
        Early and late (one year) outcomes following transcatheter aortic valve implantation in patients with severe aortic stenosis (from the United States REVIVAL trial).
        Am J Cardiol. 2011; 107: 1058-1064
        • Thomas M.
        • Schymik G.
        • Walther T.
        • Himbert D.
        • Lefèvre T.
        • Treede H.
        • Eggebrecht H.
        • Rubino P.
        • Colombo A.
        • Lange R.
        • Schwarz R.R.
        • Wendler O.
        One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve.
        Circulation. 2011; 124: 425-433
        • Smith C.R.
        • Leon M.B.
        • Mack M.J.
        • Miller D.C.
        • Moses J.W.
        • Svensson L.G.
        • Tuzcu E.M.
        • Webb J.G.
        • Fontana G.P.
        • Makkar R.R.
        • Williams M.
        • Dewey T.
        • Kapadia S.
        • Babaliaros V.
        • Thourani V.H.
        • Corso P.
        • Pichard A.D.
        • Bavaria J.E.
        • Herrmann H.C.
        • Akin J.J.
        • Anderson W.N.
        • Wang D.
        • Pocock S.J.
        • PARTNER Trial Investigators
        Transcatheter versus surgical aortic-valve replacement in high-risk patients.
        N Engl J Med. 2011; 364: 2187-2198
        • Piazza N.
        • van Gameren M.
        • Jüni P.
        • Wenaweser P.
        • Carrel T.
        • Onuma Y.
        • Gahl B.
        • Hellige G.
        • Otten A.
        • Kappetein A.P.
        • Takkenberg J.J.
        • van Domburg R.
        • de Jaegere P.
        • Serruys P.W.
        • Windecker S.
        A comparison of patient characteristics and 30-day mortality outcomes after transcatheter aortic valve implantation and surgical aortic valve replacement for the treatment of aortic stenosis: a two-centre study.
        Eurointervention. 2009; 5: 580-588
        • Walther T.
        • Schuler G.
        • Borger M.A.
        • Kempfert J.
        • Seeburger J.
        • Rückert Y.
        • Ender J.
        • Linke A.
        • Scholz M.
        • Falk V.
        • Mohr F.W.
        Transapical aortic valve implantation in 100 consecutive patients: comparison to propensity-matched conventional aortic valve replacement.
        Eur Heart J. 2010; 31: 1398-1403
        • Leon M.B.
        • Piazza N.
        • Nikolsky E.
        • Blackstone E.H.
        • Cutlip D.E.
        • Kappetein A.P.
        • Krucoff M.W.
        • Mack M.
        • Mehran R.
        • Miller C.
        • Morel M.A.
        • Petersen J.
        • Popma J.J.
        • Takkenberg J.J.
        • Vahanian A.
        • van Es G.A.
        • Vranckx P.
        • Webb J.G.
        • Windecker S.
        • Serruys P.W.
        Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium.
        J Am Coll Cardiol. 2011; 57: 253-269
        • Vahanian A.
        • Alfieri O.
        • Al-Attar N.
        • Antunes M.
        • Bax J.
        • Cormier B.
        • Cribier A.
        • De Jaegere P.
        • Fournial G.
        • Kappetein A.P.
        • Kovac J.
        • Ludgate S.
        • Maisano F.
        • Moat N.
        • Mohr F.
        • Nataf P.
        • Piérard L.
        • Pomar J.L.
        • Schofer J.
        • Tornos P.
        • Tuzcu M.
        • van Hout B.
        • Von Segesser L.K.
        • Walther T.
        • European Association of Cardio-Thoracic Surgery, European Society of Cardiology, European Association of Percutaneous Cardiovascular Interventions
        Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
        Eur Heart J. 2008; 29: 1463-1470
        • Tamburino C.
        • Capodanno D.
        • Mulè M.
        • Scarabelli M.
        • Cammalleri V.
        • Barbanti M.
        • Calafiore A.
        • Ussia G.
        Procedural success and 30-day clinical outcomes after percutaneous aortic valve replacement using current third-generation self-expanding CoreValve prosthesis.
        J Invasive Cardiol. 2009; 21: 93-98
        • Fraccaro C.
        • Napodano M.
        • Tarantini G.
        • Gasparetto V.
        • Gerosa G.
        • Bianco R.
        • Bonato R.
        • Pittarello D.
        • Isabella G.
        • Iliceto S.
        • Ramondo A.
        Expanding the eligibility for transcatheter aortic valve implantation: the trans-subclavian retrograde approach using the III generation CoreValve Revalving system.
        JACC Cardiovasc Intv. 2009; 2: 828-833
        • Ussia G.P.
        • Scarabelli M.
        • Mulè M.
        • Barbanti M.
        • Cammalleri V.
        • Immè S.
        • Aruta P.
        • Pistritto A.M.
        • Carbonaro A.
        • Deste W.
        • Sciuto P.
        • Licciardello G.
        • Calvi V.
        • Tamburino C.
        Postprocedural management of patients after transcatheter aortic valve implantation procedure with self-expanding bioprosthesis.
        Catheter Cardiovasc Interv. 2010; 76: 757-766
        • Ussia G.P.
        • Barbanti M.
        • Immè S.
        • Scarabelli M.
        • Mulè M.
        • Cammalleri V.
        • Aruta P.
        • Pistritto A.M.
        • Capodanno D.
        • Deste W.
        • Di Pasqua M.C.
        • Tamburino C.
        Management of implant failure during transcatheter aortic valve implantation.
        Catheter Cardiovasc Interv. 2010; 76: 440-449
        • Bagur R.
        • Webb J.G.
        • Nietlispach F.
        • Dumont E.
        • De Larochellière R.
        • Doyle D.
        • Masson J.B.
        • Gutièrrez M.J.
        • Clavel M.A.
        • Bertrand O.F.
        • Pibarot P.
        • Rodés-Cabau J.
        Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement.
        Eur Heart J. 2010; 31: 865-874
        • Calvi V.
        • Puzzangara E.
        • Pruiti G.P.
        • Conti S.
        • Di Grazia A.
        • Ussia G.P.
        • Capodanno D.
        • Tamburino C.
        Early conduction disorders following percutaneous aortic valve replacement.
        Pacing Clin Electrophysiol. 2009; 32: S126-S130
        • Bagur R.
        • Manazzoni J.M.
        • Dumont É.
        • Doyle D.
        • Perron J.
        • Dagenais F.
        • Mathieu P.
        • Baillot R.
        • Charbonneau É.
        • Metrás J.
        • Mohammadi S.
        • Côté M.
        • Philippon F.
        • Voisine P.
        • Rodés-Cabau J.
        Permanent pacemaker implantation following isolated aortic valve replacement in a large cohort of elderly patients with severe aortic stenosis.
        Heart. 2011; 97: 1687-1694
        • Tamburino C.
        • Barbanti M.
        • Capodanno D.
        • Sarkar K.
        • Cammalleri V.
        • Scarabelli M.
        • Mulè M.
        • Immè S.
        • Aruta P.
        • Ussia G.P.
        Early- and mid-term outcomes of transcatheter aortic valve implantation in patients with logistic EuroSCORE less than 20%: A comparative analysis between different risk strata.
        Catheter Cardiovasc Interv. 2011; 79: 132-140
        • Murphy G.J.
        • Reeves B.C.
        • Rogers C.A.
        • Rizvi S.I.
        • Culliford L.
        • Angelini G.D.
        Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery.
        Circulation. 2007; 116: 2544-2552